Therapeutic Asset Ratings

13,155 results matching 1 filter

91,564 assets · 7,904 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Adriamycin Rhabdomyosarcoma	Children's National Research Institute	P2	B (60)
Adrulipase Alfa Cystic Fibrosis	Entero Therapeutics	P2	B (60)
al8326 Non-Small Cell Lung Carcinoma	Advenchen Pharmaceuticals, LLC.	P2	B (60)
Alectinib Sarcoma	OHSU Knight Cancer Institute	P2	B (60)
Alectinib Breast Cancer	OHSU Knight Cancer Institute	P2	B (60)
Alemtuzumab Disease Related To Hematopoietic Stem Cell Transplant	University of Calgary	P2	B (60)
Alemtuzumab Hemoglobinopathy	Masonic Cancer Center, University of Minnesota	P2	B (60)
Alemtuzumab Immunodeficiency Disease	Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins	P2	B (60)
Alemtuzumab Immune System Disorder	Washington University School of Medicine	P2	B (60)
Alisertib Small Cell Lung Carcinoma	Puma Biotechnology, Inc.	P2	B (60)
Allo-501A Large B-Cell Lymphoma	Allogene Therapeutics	P2	B (60)
Allo-647 Large B-Cell Lymphoma	Allogene Therapeutics	P2	B (60)
Allopregnan-3.Alpha.-Ol-20-One Alzheimer Disease	University of Arizona	P2	B (60)
Allopurinol Acute Myeloid Leukemia	OHSU Knight Cancer Institute	P2	B (60)
Aln-Cideb Metabolic Dysfunction-Associated Steatohepatitis	Regeneron Pharmaceuticals	P2	B (60)
Alpha Tocopherol Type 2 Diabetes Mellitus	Shanghai Jiao Tong University School of Medicine	P2	B (60)
Ambroxol Lewy Body Dementia	London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's	P2	B (60)
Anakinra B-Cell Acute Lymphoblastic Leukemia	Ann & Robert H Lurie Children's Hospital of Chicago	P2	B (60)
Anastrozole Breast Disorder	Fujian Cancer Hospital	P2	B (60)
ang003 Exocrine Pancreatic Insufficiency	Anagram Therapeutics, Inc.	P2	B (60)
Anti-Human T-Lymphocyte Immunoglobulin, Rabbit Bone Marrow Failure Syndrome	M.D. Anderson Cancer Center	P2	B (60)
Aphd-012 Obesity Disorder	Aphaia Pharma US LLC	P2	B (60)
arx788 Neoplasm	Ambrx, Inc.	P2	B (60)
Asciminib Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive	The University of Hong Kong	P2	B (60)
Atezolizumab Richter Transformation	Christine Ryan	P2	B (60)

Showing 1551 to 1575 of 13,155 assets

PreviousPage 63 of 527Next